title: Switching from ticagrelor to prasugrel: a warning.
authors.affiliation: Department of Heart and Vessels, Careggi University Hospital, Florence, Italy. Electronic address: parodiguido@gmail.com.
authors.forename: Guido
authors.initials: G
authors.lastname: Parodi
authors.affiliation: Department of Heart and Vessels, Careggi University Hospital, Florence, Italy.
authors.forename: Benedetta
authors.initials: B
authors.lastname: Bellandi
authors.affiliation: Department of Heart and Vessels, Careggi University Hospital, Florence, Italy.
authors.forename: David
authors.initials: D
authors.lastname: Antoniucci
mesh_terms: D000241:Adenosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000368:Aged; D057915:Drug Substitution / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000379:methods; D010879:Piperazines / Q000008:administration & dosage* / Q000009:adverse effects*; D000068799:Prasugrel Hydrochloride; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage* / Q000009:adverse effects*; D013876:Thiophenes / Q000008:administration & dosage* / Q000009:adverse effects*; D000077486:Ticagrelor
chemical_list: D010879:Piperazines; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride; D000077486:Ticagrelor; D000241:Adenosine
keywords: NSTEMI; Platelet inhibition; Prasugrel; Stent thrombosis; Switching; Ticagrelor